Samina Hamied of Cipla is the new VP of the IPA for 2021-23
Cipla is a leading global pharma company
Cipla is a leading global pharma company
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
Subscribe To Our Newsletter & Stay Updated